| 1. |
Balakrishnan D, Oli A. Ziv-aflibercept combined with intravitreal steroid for management of peripheral exudative haemorrhagic chorioretinopathy[J/OL]. BMJ Case Rep, 2019, 12(9): e231668[2019-09-11]. https://pubmed.ncbi.nlm.nih.gov/31511273/. DOI: 10.1136/bcr-2019-231668.
|
| 2. |
Shields JA, Mashayekhi A, Ra S, et al. Pseudomelanomas of the posterior uveal tract: the 2006 Taylor R. Smith Lecture[J]. Retina, 2005, 25(6): 767-771. DOI: 10.1097/00006982-200509000-00013.
|
| 3. |
Cebeci Z, Dere Y, Bayraktar Ş, et al. Clinical features and course of patients with peripheral exudative hemorrhagic chorioretinopathy[J]. Turk J Ophthalmol, 2016, 46(5): 215-220. DOI: 10.4274/tjo.71354.
|
| 4. |
Vandefonteyne S, Caujolle JP, Rosier L, et al. Diagnosis and treatment of peripheral exudative haemorrhagic chorioretinopathy[J]. Br J Ophthalmol, 2020, 104(6): 874-878. DOI: 10.1136/bjophthalmol-2018-313307.
|
| 5. |
Yannuzzi LA, Nogueira FB, Spaide RF, et al. Idiopathic polypoidal choroidal vasculopathy: a peripheral lesion[J]. Arch Ophthalmol, 1998, 116(3): 382-383.
|
| 6. |
Karagiannis DA, Soublis V, Kandarakis A. A case of polypoidal choroidal vasculopathy. Periphery is equally important for such patients[J]. Clin Interv Aging, 2009, 4: 315-317. DOI: 10.2147/cia.s6193.
|
| 7. |
Mashayekhi A, Shields CL, Shields JA. Peripheral exudative hemorrhagic chorioretinopathy: avariant of polypoidal choroidal vasculopathy?[J]. J Ophthalmic Vis Res, 2013, 8(3): 264-267.
|
| 8. |
Anantharaman G, Ramkumar G, Gopalakrishnan M, et al. Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients[J]. Indian J Ophthalmol, 2010, 58(5): 399-405. DOI: 10.4103/0301-4738.67052.
|
